Research methods to change clinical practice for patients with rare cancers

Area of Science:

• Oncology
• Clinical Trials
• Epidemiology

Background:

• Rare cancers represent a growing clinical challenge, partly due to molecular reclassification of common cancers.
• Existing clinical trial methodologies for rare diseases may not be directly applicable to rare cancers.
• There is a critical need for robust research methods to evaluate interventions for rare cancers and inform clinical practice.

Purpose of the Study:

• To describe research methods applicable to rare cancers across various incidence levels.
• To identify strategies for maximizing patient recruitment, minimizing sample size, and enhancing evidence utility in rare cancer trials.
• To explore alternative trial designs that address the unique challenges of rare cancers.

Main Methods:

• Review of existing and novel clinical trial designs relevant to rare cancer research.
• Discussion of strategies to adapt conventional trial designs for rare cancer populations.
• Exploration of Bayesian designs, uncontrolled n-of-1 trials, and umbrella/basket trials.

Main Results:

• Conventional clinical trial designs can be adapted for rare cancers through strategies like maximizing recruitment and evidence usefulness.
• Alternative designs such as Bayesian, n-of-1, umbrella, and basket trials offer promising approaches for rare cancer research.
• Pragmatic solutions are essential to facilitate evidence-based healthcare for patients with rare cancers.

Conclusions:

• Innovative and adaptive clinical trial methodologies are necessary to generate robust evidence for rare cancers.
• The implementation of specialized trial designs can overcome challenges in rare cancer research.
• Achieving evidence-based healthcare for rare cancer patients requires pragmatic and tailored research strategies.